Archives

CAMBRIDGE, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that it has appointed David T. Scadden, M.D., to [...]

We all have been touched by cancer.  And while our family and friends still die from its many forms, seemingly resistant to a cure, at the same time we read many stories about the potential for a [...]